Fluids%2525252525252525252525252525252520in%2525252525252525252525252525252520pediatrics

# Fluids in Pediatrics ## Overview Pediatric intravenous fluid therapy requires a precise balance of maintenance needs (to support baseline metabolic demands) and deficit replacement (to correct dehydration). Fluid choice and volume are heavily dependent on patient age, weight, electrolyte status, and underlying pathophysiology. ## Primary Indications * Maintenance therapy in patients unable to meet physiological needs enterally. * Resuscitation in hypovolemia/shock. * Replacement of ongoing losses (gastrointestinal, renal, or insensible). ## Adult Dosing Standard maintenance is often estimated via the 30–35 mL/kg/day rule, though individual clinical status (renal/cardiac function) dictates specific titration. ## Pediatric Dosing Dosing typically follows the **Holliday-Segar Method** (Maintenance): * **0–10 kg:** 100 mL/kg/day. * **11–20 kg:** 1,000 mL + 50 mL/kg for every kg over 10 kg. * **>20 kg:** 1,500 mL + 20 mL/kg for every kg over 20 kg. * **Maximum:** Usually capped at 2,400 mL/day. **Resuscitation Dosing:** * **Crystalloids (e.g., 0.9% NaCl or Lactated Ringer's):** 20 mL/kg bolus administered rapidly (over 5–20 minutes), repeated as clinically indicated based on perfusion status. *Note: Dosing strictly depends on local institutional protocols and current clinical guidelines (e.g., AAP, PALS).* ## Dose Adjustments * **Dehydration Deficit:** Added to maintenance fluids and usually replaced over 12–24 hours, depending on the severity of hypernatremia or hyponatremia. * **Renal/Cardiac Disease:** Requires significant fluid restriction; monitor output and weight daily. * **Increased Losses:** Increase maintenance rates based on measured output (e.g., diarrhea, gastric suction). ## Contraindications * **Fluid Overload:** Congestive heart failure, pulmonary edema. * **Hypotonic Fluids (e.g., 0.2% NaCl, 0.45% NaCl):** Avoid in acute resuscitation or patients at risk for cerebral edema (e.g., DKA, head trauma) as they may contribute to hyponatremic encephalopathy. ## Adverse Effects * **Hyperchloremic Metabolic Acidosis:** Associated with large volumes of 0.9% NaCl. * **Hyponatremia:** Risk associated with the use of hypotonic maintenance fluids. * **Fluid Overload:** Hypertension, pulmonary edema, liver/splenic congestion. ## Key Drug Interactions * **Calcium-containing solutions:** Avoid mixing/co-administration with Ceftriaxone (risk of precipitation in IV lines/lungs/kidneys). * **Medication Diluents:** Always verify drug compatibility with the specific IV fluid (e.g., dextrose concentration, pH, electrolyte content). ## Monitoring * **Strict I/O (Input/Output):** Measure all fluids administered versus urine, stool, and drain outputs. * **Daily Weights:** The most sensitive indicator of fluid balance. * **Electrolytes (BMP):** Monitor Sodium, Potassium, and Chloride levels, specifically when using hypotonic or potassium-fortified maintenance solutions. * **Physical Exam:** Assess for peripheral/pulmonary edema, skin turgor, mucous membranes, and capillary refill. ## Clinical Pearls * **Isotonic Preference:** Current literature supports the use of isotonic fluids (e.g., Plasma-Lyte, Ringer's Acetate, or 0.9% NaCl) for maintenance in pediatric settings to reduce the risk of hospital-acquired hyponatremia. * **DKA Protocol:** Fluid management in Diabetic Ketoacidosis follows specialized protocols that often require slower rehydration to prevent cerebral edema. * **Dextrose:** Pediatric patients, especially neonates and infants, have limited glycogen stores and require dextrose in maintenance fluids to prevent hypoglycemia. *** **Disclaimer:** This information is for educational purposes only. Pediatric fluid management involves complex clinical judgment and institutional-specific protocols. Always consult current institutional clinical guidelines, pharmacy department, and verify prescribing information through official clinical resources before administration.